CAMBRIDGE, MA and ARMONK, NY / April 20, 2023 / Moderna, Inc. (Nasdaq: MRNA), a biotechnology company focused on messenger RNA (mRNA) therapeutics and vaccines, and IBM (NYSE: IBM) have announced an ...

Moderna invests in developing quantum computing skills and exploring the use of quantum computing in developing future mRNA medicines Agreement with IBM includes investments in generative AI to ...

"We are excited to partner with IBM to develop novel AI models to advance mRNA science, prepare ourselves for the era of quantum computing, and ready our business for these game-changing technologies.

"IBM's purpose is to be the catalyst to make the world work better, perfectly exemplified by this partnership with Moderna. We are witnessing a revolution in the world of computing, driven by ...

IBM and Moderna announced a new partnership today to explore the potential of generative AI and quantum computing. ... Garcia noted that Moderna is now part of the IBM Quantum Accelerator program, ...

Moderna and IBM have formed a partnership to see how cutting-edge technologies like generative artificial intelligence and quantum computing could be applied to the discovery of mRNA medicines ...

The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and ...

Under the agreement, IBM will provide access to quantum computing systems, as well as expertise to assist Moderna in exploring cutting-edge life sciences use-cases powered by quantum technologies.

While Moderna isn’t looking to replace classical computing with quantum entirely, the company is interested in building a “quantum-enabled biotechnology pipeline.” In conjunction with IBM, the ...

Moderna and IBM are joining forces to incorporate artificial intelligence (AI) and quantum computing into mRNA development, which was used to create Moderna’s COVID-19 vaccine. “We are … ...

Vaccine maker Moderna and computing giant IBM are teaming up to explore how quantum computing and artificial intelligence can develop future mRNA medicines, both companies announced on Thursday ...

There’s still plenty of room for growth as the AI race continues to unfold. Still, some growth investors are already moving ...